Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what guidance is provided to Personal Independence Payment assessors on considering the effects of active medical treatment on claimants’ functional ability.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
Personal Independence Payment (PIP) assessments focus on the functional impact of a claimant’s health condition, rather than diagnosis or treatment alone. At assessment, Health Professionals (HPs) gather information on any past, current and ongoing medical treatment related to conditions that impact function, including medication, therapy, monitoring, side effects and effectiveness. Where necessary to properly inform their advice, HPs should and routinely do seek additional evidence from treating health professionals or other appropriate sources.
Medical treatment is covered throughout training and guidance, and HPs routinely consider the effects of ongoing medical treatment on functional ability when advising on appropriate descriptors. This includes both positive effects, where treatment enables activities to be completed more reliably, and negative effects, such as side effects or symptom fluctuation. These factors are particularly important when applying the reliability criteria, including whether an activity can be carried out safely, to an acceptable standard, repeatedly, and within a reasonable time. The impact of treatment is also assessed directly within activity 3, which relates to managing therapy or monitoring a health condition.
Where symptoms fluctuate, including because of treatment variability, HPs assess functional impact over a 12-month period to reflect good and bad days and determine how descriptors apply on the majority of days. HPs also consider what medical treatment is being undertaken when advising on a recommended review date, aligning this with the point at which an individual’s functional needs could reasonably be expected to change, for example following recovery or changes to treatment. Claimants are also expected to notify the Department directly of any changes in their condition or circumstances, so that their award can be reviewed where appropriate.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how fluctuating symptoms are taken into account within Personal Independence Payment assessments.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
Personal Independence Payment (PIP) assessments focus on the functional impact of a claimant’s health condition, rather than diagnosis or treatment alone. At assessment, Health Professionals (HPs) gather information on any past, current and ongoing medical treatment related to conditions that impact function, including medication, therapy, monitoring, side effects and effectiveness. Where necessary to properly inform their advice, HPs should and routinely do seek additional evidence from treating health professionals or other appropriate sources.
Medical treatment is covered throughout training and guidance, and HPs routinely consider the effects of ongoing medical treatment on functional ability when advising on appropriate descriptors. This includes both positive effects, where treatment enables activities to be completed more reliably, and negative effects, such as side effects or symptom fluctuation. These factors are particularly important when applying the reliability criteria, including whether an activity can be carried out safely, to an acceptable standard, repeatedly, and within a reasonable time. The impact of treatment is also assessed directly within activity 3, which relates to managing therapy or monitoring a health condition.
Where symptoms fluctuate, including because of treatment variability, HPs assess functional impact over a 12-month period to reflect good and bad days and determine how descriptors apply on the majority of days. HPs also consider what medical treatment is being undertaken when advising on a recommended review date, aligning this with the point at which an individual’s functional needs could reasonably be expected to change, for example following recovery or changes to treatment. Claimants are also expected to notify the Department directly of any changes in their condition or circumstances, so that their award can be reviewed where appropriate.
Asked by: Simon Opher (Labour - Stroud)
Question to the Department for Digital, Culture, Media & Sport:
To ask the Secretary of State for Culture, Media and Sport, what steps she is taking to support orchestras.
Answered by Ian Murray - Minister of State (Department for Science, Innovation and Technology)
The Government is proud to champion our world-class orchestras and musicians, and help them to thrive. Through Arts Council England’s (ACE) 2023–26 National Portfolio Investment Programme, more money is going to more orchestral organisations in more parts of the country than ever before.The National Portfolio is supporting 139 organisations classed as ‘music’ by investing around £65 million of public funding per annum. ACE investment in classical music remains high, in particular in orchestral music organisations, with 23 such organisations being funded to the tune of around £21 million per annum. We are also supporting orchestras through the tax system, confirming from April 2025 that Orchestra Tax Relief on production costs would be set at the generous rate of 45 per cent.
Over the course of this Parliament, we will also make a £1.5 billion capital investment into fulfilling our Arts Everywhere ambitions. This funding package includes £425 million for the Creative Foundations Fund, revitalising and renewing performing arts buildings across England, including resident venues and key stops on orchestral tours. We will also, for the first time, provide £80 million of capital funding to the National Portfolio Investment Programme over the next four years. This means that Arts Council England will be able to give around 1,000 cultural organisations a 5% uplift in their regular funding; the single biggest uplift to an existing Portfolio in decades.
Asked by: Mark Pritchard (Conservative - The Wrekin)
Question to the Department for Digital, Culture, Media & Sport:
To ask the Secretary of State for Culture, Media and Sport, if she will review the decision taken earlier this year not to award funding to the Wellington Orbit from the Creative Foundations Fund.
Answered by Ian Murray - Minister of State (Department for Science, Innovation and Technology)
The Creative Foundation Fund, announced in 2025 as part of the Arts Everywhere Fund, is being delivered by Arts Council England. The Arts Council makes decisions about which organisations and projects to fund independently of government and Ministers, which means there is no question of any political involvement in arts funding decisions. It would, therefore, be inappropriate for Ministers to ask Arts Council England to revisit their decision on the application made by Wellington Orbit. Demand for this fund in its first round was extremely high, with a large number of applicants demonstrating the ability to meet the programme aims. As a result, the Arts Council had to make very difficult decisions about which applicants to invite to the full application stage. This was to ensure that applicants did not spend time and resources completing an application with very limited chance of success in that round.
The Secretary of State for Culture, Media and Sport has recently announced a new round of the Arts Everywhere Fund, including up to £340 million of new funding for the Creative Foundations Fund, which will be invested from 2026/27 up to and including 2029/30. Wellington Orbit may wish to submit an application. Arts Council England will announce further details regarding the application process and eligibility criteria in due course.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department for Digital, Culture, Media & Sport:
To ask the Secretary of State for Culture, Media and Sport, what recent discussions she has had with Formula One bodies on further support for Formula One in the UK.
Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)
Formula One is a British success story and this government is proud to champion and support the sport. My Department frequently engages with Formula One and wider stakeholders across the motorsport industry to champion the sport and identify shared opportunities including recently at the Motorsport UK Night of Champions and at the iconic British Grand Prix in July.
The Government recognises manufacturing, engineering and other STEM advances generated in our domestic motorsport sector are a vibrant part of regional growth in Motorsport Valley and beyond.
Asked by: Ian Lavery (Labour - Blyth and Ashington)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make and assessment of the potential merits of reviewing the Control of Substances Hazardous to Health Regulations 2002 to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as carcinogens and mutagens.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
I refer the hon. Member to the answer I gave on 30 October 2025 to Question UIN 84440.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure health professionals are adequately trained on the differences between Functional Neurological Disorder and other neurological conditions.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department recognises the need to improve awareness and understanding of functional neurological disorder (FND) across the health system.
The Royal College of General Practitioners provides a learning course that includes a dedicated module on recognising and explaining FND, helping general practitioners (GPs) to improve early identification and understanding of the condition. Further support is provided through guidance published by the National Institute for Care Excellence (NICE) on suspected neurological conditions: recognition and referral, reference code NG127, which includes detailed recommendations on recognising symptoms commonly present in FND and appropriate referral pathways.
NICE also provides a Clinical Knowledge Summary (CKS) on FND, offering practical, evidence‑based advice on diagnosis and management, supporting clinicians in distinguishing FND from structural or degenerative neurological disease.
FND is also included in a NICE guideline on rehabilitation for chronic neurological disorders and acquired brain injury, reference code NG252, published in October 2025. This further strengthens the evidence base and ensure clinicians have clear, up‑to‑date guidance on assessment and management within a broader neurological context.
Together, these resources ensure that health professionals, across primary, secondary, and specialist services, have access to robust, evidence‑based tools to support accurate differentiation between FND and other neurological conditions.
GPs are required to undertake continuing professional development to maintain and update their clinical knowledge, and they can access a range of training resources through professional bodies, royal colleges, and National Health Service‑funded education platforms. Decisions about mandatory training requirements are made only where there is a clear and evidence‑based need, and the current approach remains to ensure that GPs have the flexibility to tailor their learning to the needs of their patient populations.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make training on Functional Neurological Disorder mandatory for General Practitioners.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Department recognises the need to improve awareness and understanding of functional neurological disorder (FND) across the health system.
The Royal College of General Practitioners provides a learning course that includes a dedicated module on recognising and explaining FND, helping general practitioners (GPs) to improve early identification and understanding of the condition. Further support is provided through guidance published by the National Institute for Care Excellence (NICE) on suspected neurological conditions: recognition and referral, reference code NG127, which includes detailed recommendations on recognising symptoms commonly present in FND and appropriate referral pathways.
NICE also provides a Clinical Knowledge Summary (CKS) on FND, offering practical, evidence‑based advice on diagnosis and management, supporting clinicians in distinguishing FND from structural or degenerative neurological disease.
FND is also included in a NICE guideline on rehabilitation for chronic neurological disorders and acquired brain injury, reference code NG252, published in October 2025. This further strengthens the evidence base and ensure clinicians have clear, up‑to‑date guidance on assessment and management within a broader neurological context.
Together, these resources ensure that health professionals, across primary, secondary, and specialist services, have access to robust, evidence‑based tools to support accurate differentiation between FND and other neurological conditions.
GPs are required to undertake continuing professional development to maintain and update their clinical knowledge, and they can access a range of training resources through professional bodies, royal colleges, and National Health Service‑funded education platforms. Decisions about mandatory training requirements are made only where there is a clear and evidence‑based need, and the current approach remains to ensure that GPs have the flexibility to tailor their learning to the needs of their patient populations.
Asked by: Maureen Burke (Labour - Glasgow North East)
Question to the Department for Digital, Culture, Media & Sport:
To ask the Secretary of State for Culture, Media and Sport, whether she has considered establishing a dedicated regulator for the video games industry.
Answered by Ian Murray - Minister of State (Department for Science, Innovation and Technology)
The Government has not considered establishing a dedicated regulator for the video games industry. Video games are already regulated by a number of legislative and voluntary measures, governed by several enforcement bodies.
Video games are regulated with age ratings, which protect children and vulnerable people from inappropriate content. The Government works closely with the Games Rating Authority (GRA) who are designated by Government to ensure games are appropriately rated and include information for buyers on potentially harmful content, for example violence or bad language.
The Online Safety Act, made law on 26 October 2023, applies to online services which allow users to share content and interact with one another. This definition includes some video games, for example those with in-game chat functions. The Act is enforced by Ofcom.
The Advertising Standards Authority (ASA) and the Committee of Advertising Practice (CAP) are responsible for setting and enforcing the UK Advertising Codes; which includes online and in-game advertisements, such as advertising of microtransactions or loot boxes.
Finally, where video game products amount to unlicensed gambling, such as skins gambling, the Gambling Commission has shown it will take strong enforcement action.
Asked by: Ian Lavery (Labour - Blyth and Ashington)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, whether his Department plans to develop or adopt a UK list of hazardous medicinal products and to require safety data sheets for finished medicines; and if he will take steps to work with the Health and Safety Executive to make such a list publicly available to NHS employers.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
I refer the hon. Member to the answer I gave on 30 October 2025 to Question UIN 84436.